MGP
TARO

Metis Global Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Metis Global Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,938
Closed -$294K – 786
2024
Q1 		$294K Hold
6,938
– – 0.01% 662
2023
Q4 		$290K Hold
6,938
– – 0.01% 649
2023
Q3 		$262K Buy
+6,938
New +$260K 0.01% 656
2022
Q1 		– Sell
-15,268
Closed -$766K – 544
2021
Q4 		$766K Buy
+15,268
New +$855K 0.21% 106

Other funds holding TARO

KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Metis Global Partners's TARO Position: Q2 2024 in Review

Metis Global Partners sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 6,938 shares — an estimated $294K sold.

Metis Global Partners first reported a position in TARO in Q4 2021 and held it in 4 quarters. The position peaked at $766K in Q4 2021. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Metis Global Partners reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Metis Global Partners sold 6,938 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $294K.
  • Metis Global Partners first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2021 and held it in 4 quarters.
  • Metis Global Partners's Taro Pharmaceutical Industries Ltd. position peaked at $766K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Metis Global Partners's 13F filing for Q2 2024, filed 6 Aug 2024.